Revolutionizing Surgical Training: CSurgeries Partners with Sheltowee Network for Expansive Relaunch
LOUISVILLE, Ky., Sept. 27, 2023 (GLOBE NEWSWIRE) -- via IBN - CSurgeries, a top-tier online surgical video journal, is proud...
Pharmaceutical
Matinas BioPharma to Feature MAT2203 in a Pipeline Presentation at IDWeek
BEDMINSTER, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining...
Skye Bioscience Receives Clinical Site Approvals for Glaucoma Phase 2a Trial
Patient enrollment starting in Q4 2023 for proof-of-concept P2a study of CB1 agonist Phase 1 study complete and data will...
Humonix Biosciences Launches New 3D Human Tissue Model
Specialty pharmaceutical research company's new retinal vascular dysfunction model can have a major impact on research and development of new...
Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor
WALTHAM, Mass.--(BUSINESS WIRE)--Cytel Inc., provider of quantitative insights and health data analytics to leaders in the life sciences, has acquired...
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
CHICAGO, IL / ACCESSWIRE / September 26, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
COTA Announces New Data Platform to Accelerate Cancer Research and Advance Generative AI Models for Cancer Care
Vista will set the standard for automating the abstraction of oncology data critical to accelerate research and build trust in...
Rancho BioSciences Collaborates to Standardize UK Biobank Clinical Data for Improved Genetic Analysis
RANCHO SANTA FE, CA / ACCESSWIRE / September 26, 2023 / A leading global pharmaceutical company has partnered with Rancho...
Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
SAN FRANCISCO, CA / ACCESSWIRE / September 26, 2023 / In an effort to shed light on the diverse and...
Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting
Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children Analysis Shows Annualized Height Velocity...
Lexicon to Present Study Results Relating to Sotagliflozin and LX9211 at the 59th Annual Meeting of the European Association for the Study of Diabetes (EASD)
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure LX9211 is an investigational, non-opioid treatment for diabetic peripheral...
BioMech Health Wins Leading Specialists in Healthcare Real-Time Motion Analytics in the GHP Healthcare and Pharma Awards 2023
BioMech recognized for its digital advancements in healthcare, allowing patients and clinicians to quantitatively measure and monitor pre-and post-treatment function...
Synfini, Inc. Spins Out of SRI International to Bring Novel Molecular Discovery Platform to Market
Synfini Unites Neuro-Symbolic AI, Robotic Automation, and World-class Chemistry Data to Dramatically Accelerate Drug Discovery; Company Leverages More Than $40 Million in Non-dilutive SRI Development and $1M in Private Investment, Including...
Biogen Completes Acquisition of Reata Pharmaceuticals
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first and only FDA approved treatment...
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS ("bYoRNA")...
Veru Reaches Agreement with FDA on New Phase 3 Clinical Trial for Sabizabulin for Broader Indication: Hospitalized Adult Patients with Any Type of Viral Acute Respiratory Distress Syndrome (ARDS)
--Reached agreement with FDA on single Phase 3 clinical trial design to expand treatment population to include all hospitalized adult...
LIXTE Appoints Bas van der Baan as President and Chief Executive Officer
Lixte Biotechnology Holdings, Inc. Bas van der Baan, Newly Appointed President, CEO, Vice Chairman, LIXTE Biotechnology HoldingsBiotechnology Veteran Bas van...
Ambrx to Host KOL Event Discussing ARX517 Data Presented at ESMO Congress 2023
In-person event and virtual webcast to be held on Sunday, October 22, 2023 at 8:00pm CEST / 2:00pm ETSAN DIEGO,...
Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity’ for Growth, Success
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ: LSDI) announces the availability of a broadcast...
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
BERKELEY HEIGHTS, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...